Search Results 101-110 of 16403 for Chronic Lymphocytic Leukemia

  1. Acalabrutinib (oral route) - Mayo Clinic

    This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This medicine is available only with your ...

  2. Oncology (Medical) - Clinical trials - Mayo Clinic

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

  3. Living With Cancer: Myths and misunderstandings about the causes of cancer - Mayo Clinic News Network

    Chronic lymphocytic leukemia is a type of cancer of the blood and bone marrow that most commonly affects older adults. Complications include frequent infections ...

  4. Neil E. Kay, M.D. - Mayo Clinic Faculty Profiles

    The laboratory research of Neil E. Kay, M.D., is focused on B-chronic lymphocytic leukemia (CLL). This most common and still incurable leukemia is not fully ...

  5. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. Participation eligibility. Participant eligibility includes age ...

  6. Cancer Clinical Trials - Medical Professionals

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  7. Hematology - Clinical trials - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  8. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  9. Hematology - Clinical trials - Mayo Clinic

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  10. New Mayo Clinic studies to be presented at American Society of Hematology meeting

    Chronic lymphocytic leukemia is a type of cancer of the blood, and monoclonal B cell lymphocytosis is a precursor to chronic lymphocytic leukemia. Current ...